Study of Panobinostat in Patients With Neuroendocrine Tumors

This study has been completed.
Novartis Pharmaceuticals
Information provided by (Responsible Party):
University of Wisconsin, Madison Identifier:
First received: September 25, 2009
Last updated: May 28, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2015
  Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)